Neurocrine Biosciences, Inc. ( NBIX) - Key Metrics
NBIX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $8.10 | $1.54 | $3.90 | $3.93 |
| 2025Q3 | $8 | $2.11 | $2.29 | $2.16 |
| 2025Q2 | $6.94 | $1.09 | $1.03 | $0.90 |
| 2025Q1 | $5.74 | $0.08 | $0.65 | $0.54 |
NBIX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 22.95 |
| 2025Q3 | ? | 16.65 |
| 2025Q2 | ? | 28.94 |
| 2025Q1 | ? | 348.95 |
NBIX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 1.03% | ? |
| 2025Q4 | 2.77% | ? |
| 2025Q3 | 1.54% | ? |
| 2025Q2 | 0.72% | ? |
| 2025Q1 | 0.49% | ? |
NBIX
Price: $179.05
52 week price:
Earnings Per Share: 6.50 USD
P/E Ratio: 23.17
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 490000
Ebitda: 15.0 millionMarket Capitalization: 17.5 billion